Circulating Oxytocin Changes in Response to the Oxytocin System Stimulator MDMA in Patients With Diabetes Insipidus and Healthy Controls

NCT04648137 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Insipidus

Interventions

DIAGNOSTIC_TEST: study intervention: 3,4-methylenedioxymethamphetamine (MDMA, ecstasy)
DIAGNOSTIC_TEST: Control intervention: Placebo

Sponsor

University Hospital, Basel, Switzerland